- Home
- IMCR vs BDJ Comparison
IMCR vs BDJ Comparison
Compare IMCR & BDJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCR
- BDJ
- Stock Information
- Founded
- IMCR 2008
- BDJ 2005
- Country
- IMCR United Kingdom
- BDJ United States
- Employees
- IMCR N/A
- BDJ N/A
- Industry
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- BDJ Finance Companies
- Sector
- IMCR Health Care
- BDJ Finance
- Exchange
- IMCR Nasdaq
- BDJ Nasdaq
- Market Cap
- IMCR 1.6B
- BDJ 1.5B
- IPO Year
- IMCR 2021
- BDJ N/A
- Fundamental
- Price
- IMCR $35.05
- BDJ $8.80
- Analyst Decision
- IMCR Buy
- BDJ
- Analyst Count
- IMCR 10
- BDJ 0
- Target Price
- IMCR $58.13
- BDJ N/A
- AVG Volume (30 Days)
- IMCR 322.9K
- BDJ 561.6K
- Earning Date
- IMCR 08-07-2025
- BDJ 01-01-0001
- Dividend Yield
- IMCR N/A
- BDJ 8.85%
- EPS Growth
- IMCR N/A
- BDJ N/A
- EPS
- IMCR N/A
- BDJ N/A
- Revenue
- IMCR $333,581,000.00
- BDJ N/A
- Revenue This Year
- IMCR $26.82
- BDJ N/A
- Revenue Next Year
- IMCR $8.15
- BDJ N/A
- P/E Ratio
- IMCR N/A
- BDJ N/A
- Revenue Growth
- IMCR 25.75
- BDJ N/A
- 52 Week Low
- IMCR $23.15
- BDJ $6.91
- 52 Week High
- IMCR $41.54
- BDJ $8.66
- Technical
- Relative Strength Index (RSI)
- IMCR 58.09
- BDJ 54.04
- Support Level
- IMCR $32.20
- BDJ $8.84
- Resistance Level
- IMCR $35.69
- BDJ $8.97
- Average True Range (ATR)
- IMCR 1.29
- BDJ 0.08
- MACD
- IMCR 0.29
- BDJ -0.01
- Stochastic Oscillator
- IMCR 81.93
- BDJ 48.52
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.
About BDJ Blackrock Enhanced Equity Dividend Trust
BlackRock Enhanced Equity Dividend Trust is a United States closed-end management investment company. Its investment objective is to seek current income and current gains, with a secondary objective of long-term capital appreciation.